Figure 9
Recommendations for plasmatherapy to prevent post- kidney transplant recurrence of hemolytic uremic syndrome, according to the Consensus Study Group [125]. Of note, preventive eculizumab (started before transplantation) now has to be considered for patients at very high risk of recurrence. PE, plasma exchange; FFP, fresh frozen plasma.